The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2015

Filed:

Jul. 12, 2011
Applicants:

Jack L. Strominger, Cambridge, MA (US);

Masha Fridkis-hareli, Sudbury, MA (US);

Inventors:

Jack L. Strominger, Cambridge, MA (US);

Masha Fridkis-Hareli, Sudbury, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 38/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/001 (2013.01); A61K 38/2026 (2013.01); A61K 38/2066 (2013.01); A61K 38/215 (2013.01); A61K 38/02 (2013.01); Y10S 435/975 (2013.01);
Abstract

Random three- and four-amino acid copolymers having lengths of 14-, 35- and 50-amino acid residues are provided. The random copolymers have amino acids alanine, lysine and one or more of the hydrophobic amino acids valine, phenylalanine, tryptophan and tyrosine. Random three-amino acid copolymer FAK efficiently suppressed EAE induced in SJL/J (H-2S) mice with the encephalitogenic epitope PLP 139-151. Random four-amino acid copolymers VYAK and tryptophan-containing VWAK were efficacious in alleviating severity and duration of symptoms of EAE induced by MBP 85-99 (SEQ ID NO:2), in a humanized mouse model expressing genes for both an HLA-DR-2 linked to multiple sclerosis (MS) in humans and for a T cell receptor from an MS patient.


Find Patent Forward Citations

Loading…